
Amdocs Limited (NASDAQ:DOX – Free Report) – Stock analysts at Zacks Research boosted their Q1 2027 earnings estimates for shares of Amdocs in a report released on Tuesday, June 2nd. Zacks Research analyst Team now forecasts that the technology company will post earnings of $1.70 per share for the quarter, up from their previous forecast of $1.69. The consensus estimate for Amdocs’ current full-year earnings is $6.54 per share. Zacks Research also issued estimates for Amdocs’ Q2 2027 earnings at $1.70 EPS.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. Amdocs’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 EPS.
View Our Latest Analysis on Amdocs
Amdocs Stock Down 3.4%
Amdocs stock opened at $60.84 on Thursday. The firm has a market capitalization of $6.57 billion, a PE ratio of 12.17, a P/E/G ratio of 1.10 and a beta of 0.38. The company’s 50-day moving average is $64.14 and its 200-day moving average is $71.59. Amdocs has a fifty-two week low of $59.40 and a fifty-two week high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98.
Institutional Investors Weigh In On Amdocs
A number of large investors have recently bought and sold shares of the stock. WealthCollab LLC lifted its stake in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after buying an additional 173 shares in the last quarter. Atlantic Union Bankshares Corp bought a new position in shares of Amdocs during the third quarter valued at about $37,000. BOK Financial Private Wealth Inc. bought a new position in shares of Amdocs during the fourth quarter valued at about $37,000. Abich Financial Wealth Management LLC bought a new position in shares of Amdocs during the third quarter valued at about $39,000. Finally, Los Angeles Capital Management LLC bought a new position in shares of Amdocs during the fourth quarter valued at about $39,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 3.7%. The ex-dividend date is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is presently 45.60%.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Recommended Stories
- Five stocks we like better than Amdocs
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
